Global Digital Pathology Market Research Report– Global Forecast Till 2023

$4,450$6,250

Global Digital Pathology Market Research Report, by Type (Human Pathology, Animal Pathology), Product (Hardware, Software), Application (Disease Diagnosis, Mhealth, Drug Discovery) and End-Users (Hospitals, Diagnostic Centers) – Global Forecast Till 2023

Clear

Description

Introduction
Digital pathology involves converting glass slides into digital slides that can be observed, managed, shared and examined on a computer monitor. With the influx of whole-slide imaging, the framework of digital pathology saw huge growth and is currently regarded as one of the most promising avenues of diagnostic medicine. The global market for digital pathology is estimated to show a growth owing to a dearth of pathologists in the presence of cumulative demand for healthcare services, benefits associated with the use of digital pathology, increasing adoption of Electronic Health Records (EHR), and cost saving associated with the application of digital pathology. However, factors such as the high cost of implementation and stringent FDA policies are expected to restrict the market growth over the forecast period.
The global digital pathology market is expected to reach a market value of USD 8,305.6 million by 2023 from USD 3,937 million in 2017 and is expected to register a CAGR of 13.04% during the forecast period from 2018 to 2023. In 2017, the Americas held the highest share of the market at 45.3%, followed by Europe and Asia-Pacific with shares of 26.2% and 21.3%, respectively. The increasing applications of digital pathology are expected to increase the growth of the market during the forecast period.
The global digital pathology market is segmented into type, product, application, end user, and region.
The global digital pathology market, by type, is segmented into human pathology and animal pathology.
The global digital pathology market, by product, is segmented into hardware, software, and storage.
The global digital pathology market, by application, is segmented into disease diagnosis, mhealth, drug discovery, telemedicine, and others.
By end user, the global digital pathology market is segmented into hospitals and clinics, research centers and academic institutes, diagnostic centers, and others.
The global digital pathology market is expected to have a value of USD 8,305.6million by 2023 from USD 3,937 million in 2017 and is expected to register a CAGR of 13.04% during the forecast period from 2018 to 2023.
Key Players
Koninklijke Philips N.V., Olympus Corporation of the Americas, Danaher Corporation (Leica Biosystems GmbH), Inspirata, 3DHISTECH Ltd., Definiens, Huron Digital Pathology Inc, F. Hoffmann-La Roche Ltd, micro dimensions GmbH, and Mikroscan Technologies, Inc.
Study Objectives
• To provide a detailed analysis of the market structure along with the forecast of various segments and sub-segments of the digital pathology market
• To provide insights into factors affecting the market growth
• To analyze the global digital pathology market based on various tools such as supply chain analysis and Porter’s five force analysis
• To provide historical and forecast revenue of market segments and sub-segments with respect to regions and their respective key countries
• To provide country-level analysis of the market with respect to the current market size and future perspective
• To provide country-level analysis of the market for segments by type, product, application, end user, and region
• To provide strategic profiling of key players in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market
• To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the digital pathology market
Target Audience
• Hospitals and Clinics
• Research Institutes
• Pharmaceutical & Biotechnology Industries
• Suppliers and Distributors
• Potential Investors
• Raw Material Suppliers
• Government Associations
Key Findings
• The global digital pathology market is expected to reach USD 8,305.6 million by 2023 at a CAGR of 13.04% from 2018 to 2023
• On the basis of type, the human pathology segment is expected to account for the largest market share at a CAGR of 13.32% by 2023
• On the basis of product, the hardware segment is expected to account for the largest market share at a CAGR of 13.37% by 2023
• On the basis of application, the disease diagnosis segment is expected to account for the largest market share at a CAGR of 13.27% by 2023
• On the basis of end user, the research centers and academic institutes segment is expected to account for the largest market share at a CAGR of 13.34% by 2023
• The Americas is expected to hold the largest share of the global digital pathology market at a CAGR of 13.27% by 2023
• Asia-Pacific is the fastest growing market, which is expected to register a CAGR of 13.53% by 2023
Regional Analysis
• Americas
o North America
 US
 Canada
o Latin America
• Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
• Asia-Pacific
o Japan
o China
o India
o Australia
o Republic of Korea
o Rest of Asia-Pacific
• Middle East & Africa
o Middle East
o Africa

Table of Contents

Table of Contents:

1 Report Prologue
2 Executive Summary
3 Market Introduction
3.1 Definition
3.2 Scope of the Study
3.3 List of Assumptions
3.4 Market Structure
4 Research Methodology
4.1 Research Process
4.2 Primary Research
4.3 Secondary Research
4.4 Market Size Estimation
4.5 Forecast Model
5 Market Dynamics
5.1 Drivers
5.1.1 Introduction
5.1.2 Increasing spending on the healthcare IT sector
5.1.3 Increasing applications of radiology information systems
5.1.4 Rising prevalence of chronic diseases and increasing geriatric population
5.2 Restraints
5.2.1 Lack of skilled radiology professionals
5.2.2 Security Concerns
5.2.3 High cost of software
5.3 Opportunities
5.3.1 Growth potential in emerging countries.
5.4 Challenge
5.4.1 Technical errors
6 Market Factor Analysis
6.1 Porter’s Five Forces Model
6.1.1 Bargaining Power of Suppliers
6.1.2 Bargaining Power of Buyers
6.1.3 Threat of New Entrants
6.1.4 Threat of Substitutes
6.1.5 Intensity of Rivalry
6.2 Value Chain Analysis
6.2.1 Inputs
6.2.2 Software Development Processes
6.2.3 Output
6.2.4 Marketing and Distribution
6.2.5 Post-Selling Services
7 Global Radiology Information System, by Type
7.1 Overview
7.2 Integrated Radiology Information System
7.3 Standalone Radiology Information System
8 Global Radiology Information System Market,  by Component
8.1 Overview
8.2 Software
8.3 Services
8.4 Hardware
9 Global Radiology Information System Market,  by Deployment
9.1 Overview
9.2 Cloud-based/Web-based
9.3 On-premise
10 Global Radiology Information System Market,  by End-User
10.1 Overview
10.2 Hospitals & Clinics
10.3 Research & Academic Institutes
11 Global Radiology Information System Market,  by Region
11.1 Introduction
11.2 Americas
11.2.1 North America
11.2.1.1 U.S.
11.2.1.2 Canada
11.2.2 South America
11.3 Europe
11.3.1 Western Europe
11.3.1.1 Germany
11.3.1.2 France
11.3.1.3 U.K.
11.3.1.4 Italy
11.3.1.5 Spain
11.3.1.6 Rest of Western Europe
11.3.2 Eastern Europe
11.4 Asia Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Australia
11.4.5 Republic of Korea
11.4.6 Rest of Asia Pacific
11.5 Middle East & Africa
11.5.1 Middle East
11.5.2 Africa
12 Competitive Landscape
12.1 Introduction
12.2 Company Share Analysis
13 Company Profiles
13.1 IMAGE Information Systems
13.1.1 Company Overview
13.1.2 Financial Overview
13.1.3 Products Offering
13.1.4 Key Developments
13.1.5 SWOT Analysis
13.1.6 Key Strategy
13.2 Ambra Health
13.2.1 Company Overview
13.2.2 Financial Overview
13.2.3 Products Offering
13.2.4 Key Developments
13.2.5 SWOT Analysis
13.2.6 Key Strategy
13.3 Advanced Data Systems Corporation
13.3.1 Company Overview
13.3.2 Financial Overview
13.3.3 Products Offering
13.3.4 Key Developments
13.3.5 SWOT Analysis
13.3.6 Key Strategy
13.4 Carestream Health
13.4.1 Company Overview
13.4.2 Financial Overview
13.4.3 Products Offering
13.4.4 Key Developments
13.4.5 SWOT Analysis
13.4.6 Key Strategy
13.5 eRAD
13.5.1 Company Overview
13.5.2 Financial Overview
13.5.3 Products Offering
13.5.4 Key Developments
13.5.5 SWOT Analysis
13.5.6 Key Strategy
13.6 Epic Systems
13.6.1 Company Overview
13.6.2 Financial Overview
13.6.3 Products Offering
13.6.4 Key Developments
13.6.5 SWOT Analysis
13.6.6 Key Strategy
13.7 PERFECT IMAGING, LLC.
13.7.1 Company Overview
13.7.2 Financial Overview
13.7.3 Products Offering
13.7.4 Key Developments
13.7.5 SWOT Analysis
13.7.6 Key Strategy
13.8 IBM Watson Health
13.8.1 Company Overview
13.8.2 Financial Overview
13.8.3 Products Offering
13.8.4 Key Developments
13.8.5 SWOT Analysis
13.8.6 Key Strategy
13.9 Allscripts Healthcare Solutions
13.9.1 Company Overview
13.9.2 Financial Overview
13.9.3 Products Offering
13.9.4 Key Developments
13.9.5 SWOT Analysis
13.9.6 Key Strategy
13.1 Cerner Corporation
13.10.1 Company Overview
13.10.2 Financial Overview
13.10.3 Products Offering
13.10.4 Key Developments
13.10.5 SWOT Analysis
13.10.6 Key Strategy
13.11 Medinformatix, Inc
13.11.1 Company Overview
13.11.2 Financial Overview
13.11.3 Products Offering
1 Report Prologue
2 Market Introduction
2.1 Assumptions & Limitations
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Dearth of pathologists in the presence of increasing demand for healthcare services
4.2.2 Benefits associated with the use of digital pathology
4.2.3 Increasing adoption of Electronic Health Records (EHRs)
4.2.4 Cost saving associated with the application of digital pathology
4.2.5 Drivers Impact Analysis
4.3 Restraints
4.3.1 High cost of implementation
4.3.2 Restraints Impact Analysis
4.4 Opportunity
4.4.1 Untapped markets of Asia-Pacific
4.5 Macroeconomic Indicators
5 Market Factor Analysis
5.1 Value Chain Analysis
5.1.1 R&D and Designing
5.1.2 Manufacturing
5.1.3 Distribution & Sales
5.1.4 Post-Sales Review
5.2 Porter’s Five Forces Model
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Buyers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitutes
5.2.5 Intensity of Rivalry
6 Global Digital Pathology Market, by Type
6.1 Introduction
6.2 Human Pathology
6.3 Animal Pathology
7 Global Digital Pathology Market, by Product
7.1 Introduction
7.2 Hardware
7.3 Software
7.4 Storage
8 Global Digital Pathology Market, by Application
8.1 Introduction
8.2 Disease Diagnosis
8.3 Mhealth
8.4 Drug discovery
8.5 Telemedicine
9 Global Digital Pathology Market, by End Users
9.1 Introduction
9.2 Hospital & Clinic
9.3 Diagnostic Centers
9.4 Research Centers & Academic Institutes
10 Global Digital Pathology Market, by Regions
10.1 Introduction
10.2 Americas
10.2.1 North America
10.2.1.1 U.S
10.2.1.2 Canada
10.2.2 South America
10.3 Europe
10.3.1 Western Europe
10.3.1.1 Germany
10.3.1.2 U.K
10.3.1.3 France
10.3.1.4 Italy
10.3.1.5 Spain
10.3.1.6 Rest of Western Europe
10.3.2 Eastern Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 Republic of Korea
10.4.6 Rest of Asia Pacific
10.5 Middle East & Africa
10.5.1 Middle East
10.5.2 Africa
11 Competitive Landscape
11.1 Competitive Analysis
11.1.1 Introduction
11.1.2 key Developments
11.1.3 Strategies Adopted by the Market Players
12 Company Profile
12.1 Koninklijke Philips N.V.
12.1.1 Company Overview
12.1.2 Financial Overview
12.1.3 Products Offering
12.1.4 Key Developments
12.1.5 SWOT Analysis
12.1.6 Key Strategy
12.2 Olympus Corporation of the Americas
12.2.1 Company Overview
12.2.2 Financial Overview
12.2.3 Products Offering
12.2.4 Key Developments
12.2.5 SWOT Analysis
12.2.6 Key Strategy

12.3 Danaher Corporation (Leica Biosystems GmbH)
12.3.1 Company Overview
12.3.2 Financial Overview
12.3.3 Products Offering
12.3.4 Key Developments
12.3.5 SWOT Analysis
12.3.6 Key Strategy
12.4 Inspirata
12.4.1 Company Overview
12.4.2 Financial Overview
12.4.3 Products Offering
12.4.4 Key Developments
12.4.5 SWOT Analysis
12.4.6 Key Strategy
12.5 3DHISTECH Ltd.
12.5.1 Company Overview
12.5.2 Financial Overview
12.5.3 Products Offering
12.5.4 Key Developments
12.5.5 SWOT Analysis
12.5.6 Key Strategy
12.6 Definiens
12.6.1 Company Overview
12.6.2 Financial Overview
12.6.3 Products Offering
12.6.4 Key Developments
12.6.5 SWOT Analysis
12.6.6 Key Strategy
12.7 Huron Digital Pathology Inc
12.7.1 Company Overview
12.7.2 Financial Overview
12.7.3 Products Offering
12.7.4 Key Developments
12.7.5 SWOT Analysis
12.7.6 Key Strategy
12.8 F. Hoffmann-La Roche Ltd
12.8.1 Company Overview
12.8.2 Financial Overview
12.8.3 Products Offering
12.8.4 Key Developments
12.8.5 SWOT Analysis
12.8.6 Key Strategy
12.9 micro dimensions GmbH
12.9.1 Company Overview
12.9.2 Financial Overview
12.9.3 Products Offering
12.9.4 Key Developments
12.9.5 SWOT Analysis
12.9.6 Key Strategy
12.1 Mikroscan Technologies, Inc.
12.10.1 Company Overview
12.10.2 Financial Overview
12.10.3 Products Offering
12.10.4 Key Developments
12.10.5 SWOT Analysis
12.10.6 Key Strategy
13 Appendix
13.1 Discussion Blue Print

Additional information

Publisher

Geography Covered

Date Published

Pages

Format